Transoral resection of tonsillar squamous cell carcinoma

@article{Moore2009TransoralRO,
  title={Transoral resection of tonsillar squamous cell carcinoma},
  author={Eric J Moore and Douglas K. Henstrom and Kerry D. Olsen and Jan L Kasperbauer and Michaela E. McGree},
  journal={The Laryngoscope},
  year={2009},
  volume={119}
}
The tonsillar fossa is the most common subsite of the oropharynx to be afflicted with squamous cell carcinoma (SCCA). Accepted treatments include any combination of surgery, radiotherapy, and chemotherapy. We review the oncologic and functional outcomes of patients with tonsillar carcinoma who underwent transoral tumor resection and neck dissection with or without postoperative radiotherapy or chemoradiotherapy. 

Conventional transoral surgery for stage I–II squamous cell carcinoma of the tonsillar region

The purpose of this study was to review the results of conventional transoral resection and neck dissection for stage I to II squamous carcinoma of the tonsillar region.

Squamous cell carcinoma of the tonsil managed by conventional surgery and postoperative radiation

The purpose of this study was to report the long‐term outcome of patients with squamous cell cancer (SCC) of the tonsil managed by surgery followed by postoperative radiotherapy (PORT).

Long‐term results of surgical treatment for advanced oropharyngeal squamous cell carcinoma

The purpose of this study was to review the oncologic and functional outcomes of patients with clinical stage III or IV squamous cell carcinoma (SCC) of the oropharynx submitted to tumor resection

Robotic approaches to the pharynx: tonsil cancer.

Margin Analysis: Squamous Cell Carcinoma of the Oropharynx.

LOCOREGIONAL THERAPY FOR RESECTABLE OROPHARYNGEAL SQUAMOUS CELL CARCINOMAS

There is no level 1 evidence comparing definitive surgery with definitive chemoradiation, so comparing survival, local regional control, function, or quality of life between surgical and nonsurgical therapies objectively has been difficult.

ACR Appropriateness Criteria® Locoregional therapy for resectable oropharyngeal squamous cell carcinomas

There are no level I studies to guide treatment for resectable oropharyngeal squamous cell carcinoma (SCC) and ongoing investigations are examining deintensified treatments for human papillomavirus (HPV)‐associated oropharygeal SCC.

Surgical management of oropharyngeal squamous cell carcinoma: Survival and functional outcomes

The purpose of this study was to further define the impact of primary surgery in the management of oropharyngeal squamous cell carcinoma (SCC).

Current trends in initial management of hypopharyngeal cancer: The declining use of open surgery

A multidisciplinary approach is crucial in the overall management ofSquamous cell carcinoma of the hypopharynx to achieve the best results and maintain or improve functional results.

Transoral robotic surgery and human papillomavirus status: Oncologic results

Assessment of HPV‐related outcomes after transoral robotic surgery (TORS) with adjuvant therapy as indicated found patients with oropharyngeal squamous cell carcinoma have distinct outcome profiles based on their human papillomavirus (HPV) status.
...

References

SHOWING 1-10 OF 31 REFERENCES

Primary surgery as treatment for early squamous cell carcinoma of the tonsil

The management of tonsil carcinoma has gradually evolved such that the literature is replete with outcome summaries of this disease treated with primary RT and chemotherapy. Recently there have been

Management of Contralateral N0 Neck in Tonsillar Squamous Cell Carcinoma

It is well established that tonsillar squamous cell carcinomas have a high probability of disseminating to the neck, but no consensus exists whether to perform elective contralateral neck management.

Advanced‐staged tonsillar squamous carcinoma: Organ preservation versus surgical management of the primary site

Our aim was to review our experience in the management of advanced tonsillar squamous cell carcinoma (SCC) and to compare treatment outcomes between patients treated with and without surgery to the

Definitive radiotherapy for T1 and T2 squamous cell carcinoma of the tonsil

To assess whether survival or local control of early squamous cell carcinoma of the tonsil has been compromised by a moderate‐dose approach, a large number of patients diagnosed with this disease have had their tonsil removed.

Cancer of the base of the tongue: Past and future

Squamous cell carcinomas of the base of the tongue often are diagnosed at advanced stages, in a context of undernutrition with a history of smoking and alcoholism, with local treatment based on external irradiation, followed by salvage surgery in the case of failure.

Carcinoma of the tonsillar fossa: A nonrandomized comparison of irradiation alone or combined with surgery: Long‐term results

It is concluded that radiotherapy remains the treatment of choice for patients with stage T1‐T2 carcinoma of the tonsillar fossa and in selected T3‐T4 cases a combination of surgery and postoperative irradiation appears to offer better tumor control, but the possibility of greater morbidity must be considered.

Definitive Radiotherapy for Tonsillar Squamous Cell Carcinoma

Based on the data and a review of the literature, definitive RT provides cure rates that are as good as those after surgery, and is associated with a lower rate of severe complications.

Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: II. An analysis of the incidence, related variables, and consequences of local recurrence.

OBJECTIVES To determine the incidence of local and regional failure, distant metastasis, and overall survival following transoral lateral oropharyngectomy (TLO) and to determine factors associated

Transoral lateral oropharyngectomy for squamous cell carcinoma of the tonsillar region: I. Technique, complications, and functional results.

From a functional standpoint, the TLO is a reliable technique that should be considered for treatment of appropriate squamous cell carcinoma of the tonsil and/or tonsillar fossa and its safety, postoperative management, complications, and functional outcomes are described.

Carcinoma of the tonsillar fossa. An update.

A retrospective analysis of 162 patients with carcinoma of the tonsillar fossa treated between 1969 and 1983 was undertaken, and it is unable to demonstrate a significant survival advantage when surgery and radiotherapy were used in combination.